| scholarly article | Q13442814 |
| P356 | DOI | 10.1207/S15327914NC391_14 |
| P698 | PubMed publication ID | 11588890 |
| P2093 | author name string | F Raul | |
| N Seiler | |||
| B Duranton | |||
| F Gossé | |||
| Y Schneider | |||
| R Schleiffer | |||
| P433 | issue | 1 | |
| P304 | page(s) | 102-107 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Nutrition and Cancer | Q7070508 |
| P1476 | title | Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis | |
| P478 | volume | 39 |
| Q40809835 | Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147. |
| Q26800907 | An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol |
| Q36695705 | Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene |
| Q37366210 | Anti-inflammatory action of pterostilbene is mediated through the p38 mitogen-activated protein kinase pathway in colon cancer cells |
| Q33630539 | Antiproliferative effect of alcoholic extracts of some Gabonese medicinal plants on human colonic cancer cells |
| Q35859243 | Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention |
| Q36403593 | Chemoprevention of benzo(a)pyrene-induced colon polyps in ApcMin mice by resveratrol |
| Q34168543 | Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. |
| Q34624184 | Colorectal cancer: chemopreventive role of curcumin and resveratrol |
| Q50247473 | Consumer Acceptance of Bars and Gummies with Unencapsulated and Encapsulated Resveratrol |
| Q28280502 | Crystal structure of quinone reductase 2 in complex with resveratrol |
| Q43259299 | Curcumin synergizes with resveratrol to inhibit colon cancer. |
| Q41178093 | Cytotoxicity and genotoxicity of stilbene derivatives in CHO-K1 and HepG2 cell lines |
| Q84660053 | Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol:In vitroandin vivoevaluations |
| Q37307227 | Dietary activators of Sirt1 |
| Q33974480 | Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats |
| Q53343614 | Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development. |
| Q46349072 | Differential effects of wine consumption on colorectal cancer outcomes based on family history of the disease |
| Q34518736 | Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells |
| Q43245452 | Effect of resveratrol and in combination with 5-FU on murine liver cancer |
| Q33263605 | Effect of resveratrol on alcohol-induced mortality and liver lesions in mice |
| Q48024659 | Effect of resveratrol on visceral white adipose tissue inflammation and insulin sensitivity in a mouse model of sleep apnea |
| Q35755288 | Effects of a grape-supplemented diet on proliferation and Wnt signaling in the colonic mucosa are greatest for those over age 50 and with high arginine consumption |
| Q37742528 | Fighting cancer with red wine? Molecular mechanisms of resveratrol. |
| Q33985981 | Formulation and optimization of zinc-pectinate beads for the controlled delivery of resveratrol |
| Q44212204 | Hormonal and genotoxic activity of resveratrol |
| Q36844294 | Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention |
| Q34161592 | Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants |
| Q35986909 | Metabolic engineering of yeast and plants for the production of the biologically active hydroxystilbene, resveratrol. |
| Q37809351 | Molecular Targets and Clinical Cancer Risk Reductive Interventions |
| Q39640304 | Pan-PPAR agonists based on the resveratrol scaffold: biological evaluation and docking studies. |
| Q36694528 | Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene. |
| Q30252185 | Pharmacological Intervention through Dietary Nutraceuticals in Gastrointestinal Neoplasia |
| Q43862927 | Phytochemicals and colorectal cancer prevention--myth or reality? |
| Q35128757 | Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system |
| Q54968761 | Polyphenols in Colorectal Cancer: Current State of Knowledge including Clinical Trials and Molecular Mechanism of Action. |
| Q34242787 | Potential of resveratrol analogues as antagonists of osteoclasts and promoters of osteoblasts. |
| Q38131401 | Potential targets for colorectal cancer prevention. |
| Q40468988 | Prediagnostic alcohol consumption and colorectal cancer survival: The Colon Cancer Family Registry. |
| Q38718929 | Prevention and treatment of cancers by immune modulating nutrients. |
| Q44638607 | Profound negative regulatory effects by resveratrol on vascular smooth muscle cells: a role of p53–p21WAF1/CIP1 pathway |
| Q53821180 | Protective and Restorative Effects of Nutrients and Phytochemicals. |
| Q36026600 | Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography |
| Q46617346 | Red wine consumption not associated with reduced risk of colorectal cancer |
| Q34418424 | Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer |
| Q44569587 | Resveratrol analog (Z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization |
| Q30573152 | Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention |
| Q33578943 | Resveratrol and cancer: focus on in vivo evidence |
| Q33569634 | Resveratrol attenuates intermittent hypoxia-induced macrophage migration to visceral white adipose tissue and insulin resistance in male mice |
| Q37973282 | Resveratrol in human cancer chemoprevention--choosing the 'right' dose. |
| Q34586249 | Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression |
| Q41841905 | Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer |
| Q40042514 | Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes |
| Q36848141 | Resveratrol: Biological and pharmaceutical properties as anticancer molecule |
| Q24675163 | Resveratrol: a review of preclinical studies for human cancer prevention |
| Q24793084 | Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells |
| Q33750847 | Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in Apc(Min/+) mice |
| Q39540220 | Sirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells |
| Q38218129 | Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer. |
| Q28396388 | Sustained proliferation in cancer: Mechanisms and novel therapeutic targets |
| Q59449565 | Switching from high-fat diet to foods containing resveratrol as a calorie restriction mimetic changes the architecture of arcuate nucleus to produce more newborn anorexigenic neurons |
| Q47940580 | The Role of Resveratrol in Cancer Therapy. |
| Q35757899 | The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression. |
| Q36058466 | The promise of genetically engineered mice for cancer prevention studies |
| Q38211073 | The role of inflammation in colon cancer |
| Q29547413 | Therapeutic potential of resveratrol: the in vivo evidence |
| Q28080164 | Therapeutic targets of Traditional Chinese Medicine for colorectal cancer |
| Q40207752 | Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells |
| Q36495538 | Topical anti-inflammatory activity of Polygonum cuspidatum extract in the TPA model of mouse ear inflammation |
| Q42514125 | Transgenic alfalfa that accumulates piceid (trans-resveratrol-3-O-beta-D-glucopyranoside) requires the presence of beta-glucosidase to inhibit the formation of aberrant crypt foci in the colon of CF-1 mice |
| Q37075014 | Uptake of resveratrol and role of resveratrol-targeting protein, quinone reductase 2, in normally cultured human prostate cells |
| Q21089966 | What is new for an old molecule? Systematic review and recommendations on the use of resveratrol |
Search more.